Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study finds declines in heart attack hospitalizations and emergency care for possible strokes reported during onset of the COVID-19 pandemic not seen in subsequent surges.
Even if emergency personnel were able to use the best stroke assessment tool available, most patients taken directly by ambulance to a comprehensive stroke center could have been treated at a primary stroke center instead, a new Kaiser Permanente study suggests.
COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.
Kaiser Permanente researchers have developed a more precise way to assess a patient's risk of a heart attack, stroke, or other major heart-related problem within the next 60 days.
Kaiser Permanente research shows the need for increased education about the dangers of high blood pressure.
The new Kaiser Permanente study findings support previous research that suggests fear of contracting the novel coronavirus in a medical setting may have kept people from receiving critically needed medical care.
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
A broad look at an ethnically diverse sample of nearly 1 million Kaiser Permanente patients compared the individual contributions of major risk factors for heart attacks and stroke and found physical inactivity a greater risk than expected.
Continuous heart monitoring may help physicians identify patients at higher risk and tailor treatments.
Neurologists of the Kaiser Permanente Northern California Stroke FORCE team get clot-busting alteplase to patients twice as fast as the national average.